<?xml version="1.0" encoding="UTF-8"?>
<p>Interestingly, 
 <italic>Jain</italic> and co-authors analysed the vitamin D level in both asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers (IL-6; TNF-Î±, and serum ferritin) [
 <xref rid="B31-molecules-26-00632" ref-type="bibr">31</xref>]. Vitamin D deficiency and serum level of inflammatory markers were higher in the patients with severe COVID-19 symptoms. Moreover, a positive correlation was found between the fatal rate and vitamin D deficiency [
 <xref rid="B31-molecules-26-00632" ref-type="bibr">31</xref>]. Despite this evidence, which encourages a mass administration of vitamin D supplements to populations at risk of COVID-19, the study suffers some drawbacks. The current analysis has been conducted in a single centre located in India, an area with a high prevalence of vitamin D deficiency. It does not consider comorbidities, such as diabetes and hypertension [
 <xref rid="B31-molecules-26-00632" ref-type="bibr">31</xref>].
</p>
